DPP4 and type 2 diabetes mellitus: Based on the present comparison between preclinical and clinical data DPP4 inhibitors, we found no evidence supporting that any rodent species should be preferred, despite—and contrary to most other fields—rats still being the most frequently used species in T2DM research [36].